Armillariella Oral Solution Ameliorates Small Intestinal Damage in a Mouse Model of Chemotherapy-Induced Mucositis.

Background: Armillariella oral solution (AOS) shows therapeutic effect on gastrointestinal disorders. We aimed to investigate the potential efficacy of AOS on chemotherapy-induced intestinal mucositis in mice. Methods: Intestinal mucositis was induced in C57BL/6 mice by daily intraperitoneal injecti...

Descripción completa

Detalles Bibliográficos
Publicado en:Nutrition & Cancer Vol. 71; no. 7; pp. 1142 - 1153
Autores principales: Wenqin, Dong, Yaodong, Zhu, Wanji, Song, Fengli, Zhang, Li, Su, Haili, Jiang, Ping, Li, Mei, Zhang
Formato: pictorial research tables/charts Journal Article
Publicado: Taylor & Francis Ltd 2019
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=138226033&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 138226033
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        01635581
        7MS
      jtl: Nutrition & Cancer
      issn: 01635581
      maglogo: N
    pubinfo:
      dt: 2019
      vid: 71
      iid: 7
      pid: 377
      pub: Taylor & Francis Ltd
      place: Philadelphia, Pennsylvania
    artinfo:
      ui:
        138226033
        138226033
        138226033
        10.1080/01635581.2019.1599029
        138226033
      ppf: 1142
      ppct: 11
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Armillariella Oral Solution Ameliorates Small Intestinal Damage in a Mouse Model of Chemotherapy-Induced Mucositis.
      aug:
        au:
          Wenqin, Dong
          Yaodong, Zhu
          Wanji, Song
          Fengli, Zhang
          Li, Su
          Haili, Jiang
          Ping, Li
          Mei, Zhang
        affil: Department of Chinese Integrated Medicine Oncology, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, China
      sug:
        subj:
          Antibiotics, Antifungal Therapeutic Use
          Administration, Oral
          Antibiotics, Antifungal Administration and Dosage
          Chemotherapy, Cancer Adverse Effects
          Mucositis, Gastrointestinal Chemically Induced
          Intestine, Small Pathology
          Mucositis, Gastrointestinal Prevention and Control
          Animal Studies
          Mice
          Models, Biological
          Treatment Outcomes
          Administration, Intraperitoneal
          Bifidobacterium
          Lactobacillus
          Histological Techniques Methods
          Gene Expression Evaluation
          Tumor Markers, Biological
          Caspases Analysis
          Leucine Analysis
          Antigens, Tumor Analysis
          Apoptosis Evaluation
          Severity of Illness
          Diarrhea
          Weight Loss
      ab: Background: Armillariella oral solution (AOS) shows therapeutic effect on gastrointestinal disorders. We aimed to investigate the potential efficacy of AOS on chemotherapy-induced intestinal mucositis in mice. Methods: Intestinal mucositis was induced in C57BL/6 mice by daily intraperitoneal injection of 5-FU (50 mg/kg) for 7 days. Effects of AOS (at 1, 5, and 10 mL/kg), or combined Bifidobacterium and Lactobacillus (CBL, 450 mg/kg) on the accompanying morphometry and histology, expression of Ki-67, caspase-3, Lgr5 and apoptosis of intestinal crypt cells were assessed. Results: Continuous administration of 5-FU to mice caused severe intestinal mucositis, which was histologically characterized by the destruction of intestinal crypts and shortening of villi, accompanied by diarrhea and body weight loss. Daily AOS administration dose-dependently reduced the severity of intestinal mucositis, diarrhea and body weight loss. Similar beneficial effects were observed with CBL. The expression of Ki-67 and Lgr5 decreased and the expression of caspase-3, and the number of apoptotic cells increased 24 h after the first 5-FU administration (P < 0.05), and these responses were significantly reduced by AOS treatment (P < 0.05, at 5 or 10 mL/kg). Conclusions: AOS can alleviate 5-FU-induced mucositis in mice via increasing Lgr5 expression and suppressing apoptotic responses in the intestinal crypt cells.
      pubtype: Academic Journal
      doctype:
        pictorial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N